Evidence map›Paper›PMID 21800837›Full record

ArticleBiochemistry2011

The glutamine side chain at position 91 on the β5a-β5b loop of human immunodeficiency virus type 1 reverse transcriptase is required for stabilizing the dNTP binding pocket.

Nootan Pandey, Chaturbhuj A Mishra, Dinesh Manvar, Alok K Upadhyay, Tanaji T Talele, Thomas W Comollo, Neerja Kaushik-Basu, Virendra N Pandey

Abstract readComparative Study
In one paragraph

Article in Biochemistry, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact, top 94% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Nootan PandeyDepartment of Biochemistry and Molecular Biology, University of Medicine and Dentistry of New Jersey Medical School, 185 South Orange Avenue, Newark, New Jersey 07103, USA.
Chaturbhuj A Mishra
Dinesh Manvar
Alok K Upadhyay
Tanaji T Talele
Thomas W Comollo
Neerja Kaushik-Basu
Virendra N Pandey
Rutgers, The State University of New Jersey · USRutgers New Jersey Medical SchoolSt. John's University · US

Funding

STRUCTURE FUNCTION RELATIONSHIP IN HIV RTR01CA072824 · NCI · UNIV OF MED/DENT OF NJ-NJ MEDICAL SCHOOL · PI PANDEY, VIRENDRA NATH · 1996 to 2001
$523k
Structure-Based Development of nonnucleoside anti-HIV-1 RT DrugsR21AI074477 · NIAID · UNIV OF MED/DENT OF NJ-NJ MEDICAL SCHOOL · PI PANDEY, VIRENDRA NATH · 2009 to 2010
$445k
NCI NIH HHS R01 CA072824NIAID NIH HHS AI074477NIAID NIH HHS R21 AI074477
6 · The paper itself

Abstract

Earlier, we postulated that Gln91 of human immunodeficiency virus type 1 reverse transcriptase (HIV-1 RT) stabilizes the side chain of Tyr183 via hydrogen bonding interaction between O(H) of Tyr183 and CO of Q91 [Harris, D., et al. (1998) Biochemistry 37, 9630-9640]. To test this hypothesis, we generated mutant derivatives of Gln91 and analyzed their biochemical properties. The efficiency of reverse transcription was severely impaired by nonconservative substitution of Gln with Ala, while conservative substitution of Gln with Asn resulted in an approximately 70% loss of activity, a value similar to that observed with the Y183F mutation. The loss of polymerase activity from both Q91A and Q91N was significantly improved by a Met to Val substitution at position 184. Curiously, the Q91N mutant exhibited stringency in discriminating between correct and incorrect nucleotides, suggesting its possible interaction with residues influencing the flexibility of the dNTP binding pocket. In contrast, both double mutants, Q91A/M184V and Q91N/M184V, are found to be as error prone as the wild-type enzyme. We propose a model that suggests that subtle structural changes in the region due to mutation at position 91 may influence the stability of the side chain of Tyr183 in the catalytic YMDD motif of the enzyme, thus altering the active site geometry that may interfere in substrate recognition.

Indexed as

Amino Acid MotifsAmino Acid SubstitutionBinding SitesCatalysisCatalytic DomainCrystallography, X-RayDeoxyribonucleotidesGlutamineHIV Reverse TranscriptaseHumansProtein StabilityProtein Structure, SecondarySubstrate SpecificityTyrosineDeoxyribonucleotidesGlutamineHIV Reverse Transcriptasereverse transcriptase, Human immunodeficiency virus 1Tyrosine

Identifiers

PMID21800837
PMCPMC3204787
OpenAlexW1966066342

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.